DHEA for Ovarian Reserve: Can It Really Improve Your Egg Supply?

Diminished ovarian reserve (DOR) is one of the most challenging diagnoses in reproductive medicine. Women with low AMH levels or low antral follicle counts often face poor IVF responses and reduced natural conception chances. DHEA (dehydroepiandrosterone) has emerged as one of the most studied supplements for addressing this challenge.

What Is DHEA and Why Does It Matter for Fertility?

DHEA is a prohormone produced primarily by the adrenal glands. It serves as a precursor to both testosterone and estrogen. In the ovary, DHEA is converted locally into androgens, which play a critical role in early follicle development. Without adequate androgen signaling, small antral follicles fail to develop into mature, fertilizable eggs. Research by Dr. Norbert Gleicher and colleagues at the Center for Human Reproduction pioneered the use of DHEA to address androgen insufficiency in the ovarian microenvironment.

The Evidence for DHEA and Ovarian Reserve

Multiple studies and cohort analyses suggest DHEA supplementation improves outcomes in women with diminished ovarian reserve. Key findings include:

• Improved AMH levels after 12–16 weeks of DHEA supplementation
• Higher antral follicle counts in some studies
• Better ovarian response to gonadotropin stimulation in IVF
• Reduced aneuploidy rates in retrieved embryos
• Higher cumulative live birth rates compared to historical controls

The most commonly cited mechanism is that DHEA increases intraovarian testosterone, which activates androgen receptors on granulosa cells and promotes follicle growth. A 2010 study found that women who supplemented with DHEA for at least 16 weeks before IVF had significantly lower rates of chromosomally abnormal embryos.

Who Should Consider DHEA?

DHEA is most appropriate for women with confirmed diminished ovarian reserve, typically defined as AMH below 1.0 ng/mL, antral follicle count below 5–7, or previous poor ovarian response to stimulation. It is not recommended for women with normal ovarian reserve, as excess androgen exposure can impair follicle development in those cases.

Women with PCOS should avoid DHEA, since they already have elevated androgen levels. Women with hormone-sensitive conditions should consult a reproductive endocrinologist before use.

Dosage and Duration

The most studied protocol uses 25–75 mg of micronized DHEA daily, with most clinics recommending 75 mg. Because DHEA must accumulate in ovarian tissue and influence a full follicle development cycle, the minimum treatment duration before IVF is 6–8 weeks, with 12–16 weeks being the standard recommendation for maximum benefit.

DHEA should be taken in the morning, as it naturally peaks in the morning hours and taking it at night may interfere with sleep. Micronized DHEA (versus synthetic) is preferred for more predictable absorption.

Monitoring and Safety

DHEA can cause androgenic side effects including acne, oily skin, and increased facial hair, particularly at higher doses. Blood levels of DHEA-S (the sulfated form) should be tested before starting and periodically during supplementation to avoid supraphysiologic levels. Many reproductive endocrinologists target DHEA-S levels in the upper range of normal for a woman's age. Liver function should be monitored with extended use.

FAQ

Q: Can DHEA increase AMH levels? A: Some studies report modest increases in AMH after 12 or more weeks of DHEA supplementation, suggesting actual recruitment of additional follicles. However, results are variable and DHEA cannot restore previously depleted follicle pools.

Q: How long does it take for DHEA to work? A: Most research suggests a minimum of 6–8 weeks, with peak benefits seen at 12–16 weeks of continuous use before an IVF retrieval.

Q: Should I take DHEA without a doctor's guidance? A: DHEA is available over the counter but should not be self-prescribed for fertility without consulting a reproductive endocrinologist. Baseline hormone testing is essential to confirm you are an appropriate candidate.

Q: Is DHEA the same as testosterone? A: No. DHEA is a precursor that the body converts into testosterone and estrogen in a tissue-specific manner. It has a more targeted effect on the ovarian microenvironment compared to direct testosterone supplementation.

Related Articles

• DHEA and Ovarian Reserve: What Women with DOR Need to Know
• Antioxidants and Sperm DNA Fragmentation: A Complete Guide
• Ashwagandha for Male Fertility: Testosterone, Sperm, and Stress Relief
• CoQ10 for Egg Quality: What the Research Actually Shows
• CoQ10 for Egg Quality: Dosage, Timing, and What the Research Shows

Track your supplements in Optimize.